Life Sciences

Our life sciences specialists have an in-depth understanding of the corporate, commercial, intellectual property and employment issues affecting this sector.

The cross-firm team provides the range of legal services required by clients across the industry spectrum, from biotechnology, pharmaceuticals and medical devices companies to institutions or organisations that are involved in the research, development and sale of medicines, medical devices or nutritional products.

We advise on all aspects of UK and international acquisitions, disposals, joint ventures, developments and other transactions undertaken by clients, including structuring and financing, and have experience of public market fundraisings for many life science businesses.

Our expertise extends to all related areas of commercial activity, with the team advising on product licensing, manufacturing and distribution agreements, as well as IP protection and commercialisation.

Nigel Gordon

Nigel Gordon

If you have any questions or queries please call Nigel on +44 (0)20 3036 7389 or email ngordon@fladgate.com

International-flavoured practice handling a wide range of transactions.

Chambers UK

Industries

Life Sciences team

 

NHSX sets out UK’s COVID-19 contact tracing strategy

Tim Wright

NHSX publishes new standard for digital health technology

Fladgate advises Seko S.p.A on the acquisition of the Brightwell Group

Julian Lewis, James Fry, Hamilton Forrest, Nathan Carter-Smith, Gemma Grunewald, Alex Haffner, Luke Morris, Caroline Philipps

Fladgate’s Corporate team is further strengthened with the appointment of outsourcing and technology partner Tim Wright

Tim Wright

Fladgate LLP achieves across the board rankings in Legal 500 for 2018

Fladgate advises Sylphar N.V. on its acquisition of majority stakes in Pro Teeth Whitening Co Ltd and Nutravita Ltd

Personal data: a global commodity subject to regional rules

Fladgate advises WideCells on its £2m placing and publication of related prospectus

European Unified Patent Court agreement ratified by the UK

Fladgate LLP advises on the acquisition of a £260m development site in Luton

View by: Grid

European Unified Patent Court agreement ratified by the UK

Eddie Powell |

Fladgate LLP advises on the acquisition of a £260m development site in Luton

Miles Crawford, Marc Sosnow |

Fladgate advises Stonehealth Alpha on purchase of portfolio of five health centre properties across the UK

Gavin Whitney, Seetal Modi, David Baverstock |

Suspension following disciplinary allegations: neutral act or breach of trust and confidence?

Mike Tremeer |

WideCells sets course for synergistic growth

Paul Airley |

Fladgate advises WideCells Group PLC on placing

Paul Airley |

2017 Legal 500 ranks Fladgate across the board

Julian Lewis, Amy Collins, Andrew Kaufman, Graham Spitz, Richard Kaufman, Eddie Powell, Jonathan Hibberts, Helena Luckhurst, Mark Saunders, Alex Kaufmann, Alan Wetterhahn, Mark Harnett, Avram Kelman, Neil Vickers, Michael McCartney, Nigel Gordon, Paul Airley, Gideon Dabby-Joory, Alexander Wildschütz, Mark Buckley, Janet Keeley, Eugene Matveichuk, Bree Taylor, Sophia Purkis, Steven Mash, Stephen Lewis, Alison Mould, James Earl, Mike Tremeer, Kim McMurray, Amanda Hado-Bodfield, David Weare, Gary Smith, Luke Morris, Seetal Modi, Jenny Sargeant, Grant Gordon, David Robinson, Taj Rehal, David Baverstock, Richard Reuben, Digby Hebbard, Teresa Cullen, Ian Brent, Jeremy Whiteson |

Fladgate advises WideCells Group PLC on recent placing

Paul Airley |

2016 Legal 500 ranks Fladgate across the board

Amy Collins, Graham Spitz, Richard Kaufman, Eddie Powell, Gillian Birkby, Alan Wetterhahn, Mark Harnett, Avram Kelman, Michael McCartney, Nigel Gordon, Paul Airley, Gideon Dabby-Joory, Alexander Wildschütz, Mark Buckley, Janet Keeley, Bree Taylor, Sophia Purkis, Steven Mash, Alison Mould, James Earl, Mike Tremeer, Kim McMurray, David Weare, Luke Morris, Grant Gordon, David Robinson, Taj Rehal, Richard Reuben, Digby Hebbard, Teresa Cullen, Jeremy Whiteson |

WideCells Group PLC joins London Stock Exchange’s Main Market

Eddie Powell, Paul Airley, Jamie Hamilton, Grant Gordon |

Top 10 ranking in AIM table for Fladgate

Avram Kelman, Neil Vickers, Nigel Gordon, Paul Airley, Grant Gordon, David Robinson |

Fladgate boosts AIM and life sciences practice with appointment of corporate team

Charles Wander, Nigel Gordon, Grant Gordon |

The employment team at Fladgate LLP “saw substantial growth in 2015 with the recruitment of Michael McCartney … The team recently advised Alliance Pharma on the employment elements of its acquisition of 27 products from Sinclair Pharma.”

Legal 500

Fladgate LLP’s “approach is pragmatic and constructive”, with its “very knowledgeable lawyers providing excellent service”.

Legal 500

Nigel Gordon is “a capital markets lawyer with a great deal of experience advising AIM and TSX-listed clients on finance and M&A activity”.

Chambers UK

Chris Chrysanthou is “praised for being practical and outcome-focused”.

Legal 500

Fladgate LLP advises on a broad variety of contracts… A “high level of service and quality” is provided by the eight-partner [commercial] team, led by Eddie Powell.

Legal 500

Michael McCartney led advice to Alliance Pharma on the employment aspects of its acquisition of Macuvision.

Legal 500

International-flavoured practice handling a wide range of transactions… “Excellent and client-driven with senior partners leading from the front in the management and delivery of transaction advice.”

Chambers UK

‘Excellent in terms of being able to understand the problems at hand and provide pragmatic advice’, Fladgate LLP’s ‘versatile’ department is regularly called on to handle the employment aspects of complex transactions with a multi-jurisdictional element. Michael McCartney led advice to Ipsen Biopharmaceuticals on the relocation of 60 employees from Slough to Oxford.

Legal 500

  • Alliance Pharma – acquisition of companies and products, including the non-aesthetics business of Sinclair IS Pharma plc for £131m.
  • Synairgen – admission to AIM and a £10.5m placing.
  • Oxford Pharmascience – placing of new ordinary shares and admission to AIM, together with a secondary placing raising £20m.
  • Medgenics – advising the nominated adviser and broker on the admission of Medgenics to trading on AIM together with a placing.
  • Toumaz – advising this AIM listed company on its digital plaster technology.
  • Morria Biopharmaceuticals – listing of American Depositary Receipts on the US OTC Bulletin.
  • Life sciences venture capital companies – advising investors on the disposal of its investments in three life sciences venture capital companies based in England, Cyprus and India to a large US life sciences company for a value of over US$18.5m.
  • Wanbury Limited – listing of €15m of unsecured foreign currency convertible bonds on the Luxembourg Stock Exchange for this Indian pharmaceutical company.
  • Neubourg Skin Care – joint venture arrangements in relation to UK market entry.
  • Celsus Therapeutics – public offering of American Depositary Shares on NASDAQ for this emerging growth, development-stage biotech company.
  • GeneOnyx and its UK operating subsidiary Geneu – negotiation of supply agreements with several key packaging and product suppliers, including the provision of testing chips from the manufacturer, and an exclusive licence to market the technology in the consumer cosmetic space.
  • Canopus Biopharma – restructuring of its IP licensing in relation to the clinical trials of OLTIPRAZ and MOGROSIDES drugs.
  • Ipsen, Takeda and Alliance Pharma – various employment matters.

Integrated

Our clients come to us to solve problems that are often complex and multifaceted. We draw together the multiple strands of a business or personal challenge into a coherent, integrated legal response that combines the knowledge and experience of experts in all the relevant fields.

Partner-led

We operate in small teams in which partners not only take the lead but also do a significant amount of the detailed work. Clients can be assured that the partners they engage and brief will remain closely involved in developing and delivering the advice as part of our close-knit, expert teams.

Experienced

Fladgate has a long heritage of delivering high-quality legal advice. We have been providing practical legal solutions to businesses and private clients for over 250 years. Today we are one of the UK’s top 100 law firms, with over 80 partners and a reputation for providing solutions that work.